T

Traditional high-tech industry rivals IBM and AT&T compete in many spheres—from selling personal computers to garnering Nobel Prizes. But an area of particular fascination for scientists is their ongoing competition in basic and applied research. In 1987, the two titans again went head-to-head. They both, for example, went all out in pursuing high-temperature superconducting ceramic oxides and new technology leading to improved semiconductors. But there were significant differ- ences in

Written byDavid Pendlebury
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Traditional high-tech industry rivals IBM and AT&T compete in many spheres—from selling personal computers to garnering Nobel Prizes. But an area of particular fascination for scientists is their ongoing competition in basic and applied research. In 1987, the two titans again went head-to-head. They both, for example, went all out in pursuing high-temperature superconducting ceramic oxides and new technology leading to improved semiconductors.

But there were significant differ- ences in their concentration of research activities as well.

IBM scientists focused on the study of material surfaces and solid-liquid interfaces using scanning tunneling microscopy (invented by IBM scientists Gerd Binnig and Heinrich Rohrer), on ion-beam etching of silicon, and on the use of polycrystalline silicon for bipolar transistors.

AT&T scientists took a keen interest in several areas relating to quantum-well structures, perhaps the most active field of current semiconductor research. IBM, too, was active in researching quantum wells, but not to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies